"Subho Mozumdar, a faculty member at the University of Delhi, pointed out the problem linking diabetes and obesity: One problem commonly associated with insulin treatment is that patients gain weight, and weight gain paradoxically causes diabetes. Hence an effective GLP-1 based therapeutic could be revolutionary, as it also reduces obesity."
New Delhi, May 6 - A new research is paving the way for the discovery of a once a week drug for diabetes and obesity.

The research by Arnab De and Richard DiMarchi at US' Indiana University is leading towards development of a new potential, alternative drug candidate for diabetes and obesity, which needs to be taken only once a week, a release said here Tuesday.

Diabetes patients often have to take an insulin injection after every meal. An overdose of insulin may drastically reduce blood glucose leading to life-threatening diabetic coma. Hence we wanted to develop a non-insulin drug, which would hopefully act for a prolonged period of time so that patients do not need to take it every day, De said.

He further said: Around the time I started the work, there was this peptide hormone called GLP1, which reduces blood sugar and obesity without the accompanying risk of coma. However, it could not be used as it is very unstable and breaks down within minutes inside the body.

Now according to the research coauthored by the two scientists, they envisioned a prodrug of GLP to extend the duration of action of this peptide hormone and their research succeeded in prolonging peptide hormone action to once-a-day and once-a-week formulations.

A prodrug is a medication that is administered in an inactive or less than fully active form and then it becomes converted to its active form through a normal metabolic process,

Subho Mozumdar, a faculty member at the University of Delhi, pointed out the problem linking diabetes and obesity: One problem commonly associated with insulin treatment is that patients gain weight, and weight gain paradoxically causes diabetes. Hence an effective GLP-1 based therapeutic could be revolutionary, as it also reduces obesity.

A daily or weekly drug formulation makes it even easier for patients. This could have a huge market given the epidemic of diabetes, he said.


comments powered by Disqus
Read more on:
 INDIA (136901 views)
 DELHI (98281 views)
 NEW DELHI (71931 views)
 RESEARCH (16031 views)
 SCIENTISTS (13481 views)
 BLOOD (11961 views)
 UCC (7251 views)
 TUESDAY (6681 views)
 TREATMENT (6241 views)
 MAY 6 (4231 views)
 DIANA (4191 views)
 TIDE (1871 views)
 NEW RESEARCH (1611 views)
 ALTERNATIVE (81 views)
 

PERMALINK

http://www.nerve.in/news:2535002372285
You can quote the permanent link above for a direct link to the story. We do not archive or expire our news stories.


STORY OPTIONS
  Email this story to a friend
  XML feed for India


 
COPYRIGHTS INFORMATION
All rights reserved for news content. Reproduction, storage or redistribution of Nerve content and articles in any medium is strictly prohibited.
Contact Nerve Staff for any feedback, corrections and omissions in news stories.
 

All rights reserved for the news content. Reproduction, storage or redistribution of Nerve content and articles in any medium is strictly prohibited.